CEFAZOLINE QILU 1 g, poudre pour solution injectable/pour perfusion — 10 flacons en verre de 10 ml

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930154595
  • CIP7 3015459
  • CIS 67504598

What the source publishes

Holder
QILU PHARMA SPAIN (ESPAGNE)
Active ingredients
CÉFAZOLINE SODIQUE, CÉFAZOLINE
Form
poudre pour solution injectable ou pour perfusion
Package
10 flacons en verre de 10 ml
Routes
intramusculaire, intraveineuse
Administrative status
authorised
Supply regime
liste I
Marketing status
Déclaration de commercialisation
Authorised on
2018-07-30
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930154595
{
  "cis": "67504598",
  "cip7": "3015459",
  "form": "poudre pour solution injectable ou pour perfusion",
  "name": "CEFAZOLINE QILU 1 g, poudre pour solution injectable/pour perfusion — 10 flacons en verre de 10 ml",
  "cip13": "3400930154595",
  "holder": "QILU PHARMA SPAIN (ESPAGNE)",
  "routes": [
    "intramusculaire",
    "intraveineuse"
  ],
  "holders": [
    "QILU PHARMA SPAIN (ESPAGNE)"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": null,
  "authorisedOn": "2018-07-30",
  "compositions": [
    {
      "name": "CÉFAZOLINE SODIQUE",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "1",
      "substanceCode": "04726",
      "dosageReference": null,
      "pharmaceuticalElement": "poudre"
    },
    {
      "name": "CÉFAZOLINE",
      "nature": "FT",
      "strength": "1 g",
      "linkageNumber": "1",
      "substanceCode": "19757",
      "dosageReference": "un flacon",
      "pharmaceuticalElement": "poudre"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": null,
  "medicinePrice": null,
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "CEFAZOLINE QILU 1 g, poudre pour solution injectable/pour perfusion",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "10 flacons en verre de 10 ml",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [],
  "marketingDeclaredOn": "2026-01-05",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "CÉFAZOLINE SODIQUE",
    "CÉFAZOLINE"
  ],
  "authorisationProcedure": "Procédure décentralisée",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930154595"